Thursday, July 9, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Cue Biopharma, Inc.”

30 pharma patents match "Cue Biopharma, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 30
Index total 30,257
Page 2 / 2

Quick answer

This filtered view shows 30 pharmaceutical patents matching "Cue Biopharma, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

30 results for “Cue Biopharma, Inc.” · 30,257 patents in full index Clear search

  1. US 11377478

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted
  2. US 11370821

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  3. US 11117945

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  4. US 11104712

    Methods for modulating an immune response

    Cue Biopharma, Inc. · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  5. US 10927161

    Methods for modulating an immune response

    Cue Biopharma, Inc. · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  6. US 10927158

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted